前列腺癌的细胞免疫疗法:从15年的Sipuleucel-T中吸取的经验教训
Neal D Shore1, Emmanuel S Antonarakis2, Jason Hafron3
1Genitourinary Oncology Center of Excellence, START Carolinas/Carolina Urologic Research Center, Myrtle Beach, South Carolina, USA.
Prostate cancer
|January 7, 2026
概括
Sipuleucel-T是转移性割耐性前列腺癌 (mCRPC) 的细胞免疫疗法,提供了一种独特的向PAP表达细胞的机制. 现实世界的数据证实了其对生存的益处,并突出了影响mCRPC结果的患者因素.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 前列腺癌研究 研究前列腺癌
背景情况:
- Sipuleucel-T是第一个用于转移性割耐性前列腺癌 (mCRPC) 的细胞免疫疗法,于15年前获得批准.
- 自其批准以来,晚期前列腺癌的治疗环境发生了重大变化.
- Sipuleucel-T是一种个性化免疫疗法,激活患者的免疫系统,对抗前列腺酸酸酶 (PAP) 表达瘤细胞.
研究的目的:
- 在mCRPC患者中审查sipuleucel-T的临床益处和免疫反应.
- 确定与改善生存率相关的患者特异性因素.
- 在当前的mCRPC治疗模式中强调sipuleucel-T的独特机制.
主要方法:
- 对mCRPC中sipuleucel-T的临床试验和现实世界的数据的审查.
- 通过sipuleucel-T.诱导的免疫和生物反应的分析.
- 鉴定与sipuleucel-T.治疗的患者生存的预后因素.
主要成果:
- 在非阿片类药物需要mCRPC的患者中,Sipuleucel-T显示出生存益处.
- 广泛的数据证实了sipuleucel-T的临床疗效及其诱导免疫反应.
- 患者的种族,基线疾病负担和治疗诱导的免疫反应与更长的存活率有关.
结论:
- 由于其独特的作用机制,Sipuleucel-T仍然是mCRPC的独特治疗选择.
- 在mCRPC中最大限度地提高sipuleucel-T的适当临床利用是至关重要的.
- 进一步了解sipuleucel-T在组合疗法中的作用可能会提高其效用.
更多相关视频
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.7K
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.9K
相关概念视频
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
01:30Cancer Vaccines
946
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
946
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K